cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
An2 Therapeutics Inc
1 own
3 watching
Current Price
$1.26
$0.03
(2.87%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
59.53M
52-Week High
52-Week High
21.55000
52-Week Low
52-Week Low
0.87000000
Average Volume
Average Volume
0.17M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization59.53M
icon52-Week High21.55000
icon52-Week Low0.87000000
iconAverage Volume0.17M
iconDividend Yield--
iconP/E Ratio--
What does the An2 Therapeutics Inc do?
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Read More
How much money does An2 Therapeutics Inc make?
News & Events about An2 Therapeutics Inc.
PR Newswire
1 year ago
Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results PR Newswire DURHAM, N.C. and BEIJING, March 24, 2023 Company maintains priority focus on clinical programs to develop a...
PR Newswire
2years ago
Thinking about buying stock in AN2 Therapeutics, AMTD IDEA Group, Dynavax Technologies, Yelp, or Honest Company? Thinking about buying stock in AN2 Therapeutics, AMTD IDEA Group, Dynavax Technologies, Yelp, or Honest Company? PR Newswire NEW YORK, Aug. 5, 2022 NEW YORK, Aug. 5, 2022 /PRNewswire...
Globe Newswire
2years ago
MENLO PARK, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced the pricing of its upsized initial public offering of 4...
Frequently Asked Questions
Frequently Asked Questions
What is An2 Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy An2 Therapeutics Inc shares?
plus_minus_icon
How can I buy An2 Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of An2 Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in An2 Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of An2 Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of An2 Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of An2 Therapeutics Inc?
plus_minus_icon
What percentage is An2 Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is An2 Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.26
$0.03
(2.87%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
RETRACTABLE TECHNOLOGIES INC
RETRACTABLE TECHNOLOGIES INC
$0.79
$0.03 (3.46 %)
ONCOCYTE CORP
ONCOCYTE CORP
$2.20
$0.05 (2.33 %)
AFFIMED NV
AFFIMED NV
$1.08
$0.01 (0.93 %)
Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc
$0.63
$-0.00 (-0.19 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
RETRACTABLE TECHNOLOGIES INC
RETRACTABLE TECHNOLOGIES INC
$0.79
$0.03 (3.46 %)
ONCOCYTE CORP
ONCOCYTE CORP
$2.20
$0.05 (2.33 %)
AFFIMED NV
AFFIMED NV
$1.08
$0.01 (0.93 %)
Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc
$0.63
$-0.00 (-0.19 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00